Trial intelligence / Profile preview

Amoxicillin Prophylaxis for Third Molar Surgery

NCT03130933Phase 2Completed

Sponsor
University of Zagreb
Start
Apr 2010
Primary completion
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of amoxicillin in surgical site infection (SSI) and alveolar osteitis (AO) (4 arms), sponsored by University of Zagreb. Primary endpoint: Postoperative Pain at 7 days. Started Apr 2010; status: completed.

02

Drugs

amoxicillin
03

Conditions

surgical site infection (SSI)alveolar osteitis (AO)

Beyond the preview

Go deeper on NCT03130933.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03130933.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call